胃癌病人来源的类器官模型的构建及鉴定

    Construction and identification of organoid models derived from gastric cancer patients

    • 摘要:
      目的: 探索构建胃癌病人来源的类器官模型,并对建立的类器官模型进行初步评估。
      方法: 收集胃癌病人术中新鲜组织,采用酶解法,将胃癌组织解离为单细胞悬液,并在基质胶(Matrigel)中培养7天。利用苏木精–伊红染色技术对比了病人原发组织与对应PDO的形态学特征,并通过免疫组织化学染色方法检测了PDO中癌胚抗原(CEA)及增殖细胞核抗原(Ki–67)的表达水平。
      结果: 共纳入4例胃癌病人的手术样本,构建了3例可稳定传代并冻存的胃癌PDO模型,存活率75%;H&E染色结果显示PDO与原发胃癌组织的结构高度相似,免疫组化染色进一步证实PDO与原发胃癌组织中Ki–67和CEA的表达模式基本一致。
      结论: 建立与原发胃癌组织在组织和细胞层面高度一致的胃癌PDO模型,该模型具备稳定传代和长期冻存的能力,有望为胃癌的药物筛选和基础研究提供强有力的实验平台。

       

      Abstract:
      Objective To explore the construction of organoid models derived from gastric cancer patients, and conduct a preliminary assessment of the established organoid models.
      Methods The fresh tissues from patients with gastric cancer during the operation were collected. The gastric cancer tissues were dissociated into single-cell suspensions by enzymatic hydrolysis, and cultured in Matrigel for 7 days. The morphological characteristics of the primary tissues of patients and corresponding PDO were compared by hematoxylin-eosin staining technique, and the expression levels of carcinoembryonic antigen (CEA) and proliferating cell nuclear antigen (Ki-67) in PDO were detected by immunohistochemical staining method.
      Results A total of 4 surgical samples from gastric cancer patients were included. Three gastric cancer PDO models that could be stably passaged and cryopreserved were constructed, with a survival rate of 75%. The results of H&E staining showed that the structure of PDO was highly similar to that of the primary gastric cancer tissue. The results of immunohistochemical staining further confirmed that the expression patterns of Ki-67 and CEA in PDO were basically consistent with those in the primary gastric cancer tissue.
      Conclusions A PDO model of gastric cancer that is highly consistent with the primary gastric cancer tissue at the tissue and cellular levels has been established. This model has the ability of stable passage and long-term cryopreservation, and is expected to provide a powerful experimental platform for drug screening and basic research of gastric cancer.

       

    /

    返回文章
    返回